These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18281378)

  • 21. Considerations in the choice of oral vs. transdermal hormone therapy: a review.
    Minkin MJ
    J Reprod Med; 2004 Apr; 49(4):311-20. PubMed ID: 15134159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
    Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
    Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women.
    Saitta A; Altavilla D; Cucinotta D; Morabito N; Frisina N; Corrado F; D'Anna R; Lasco A; Squadrito G; Gaudio A; Cancellieri F; Arcoraci V; Squadrito F
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1512-9. PubMed ID: 11557681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative pharmacokinetics and pharmacodynamics after subcutaneous and intramuscular administration of medroxyprogesterone acetate (25 mg) and estradiol cypionate (5 mg).
    Sierra-Ramírez JA; Lara-Ricalde R; Lujan M; Velázquez-Ramírez N; Godínez-Victoria M; Hernádez-Munguía IA; Padilla A; Garza-Flores J
    Contraception; 2011 Dec; 84(6):565-70. PubMed ID: 22078184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance.
    Sorensen MB; Collins P; Ong PJ; Webb CM; Hayward CS; Asbury EA; Gatehouse PD; Elkington AG; Yang GZ; Kubba A; Pennell DJ
    Circulation; 2002 Sep; 106(13):1646-51. PubMed ID: 12270857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of hot flushes on cardiovascular autonomic responsiveness: a randomized controlled trial on hormone therapy.
    Hautamäki H; Haapalahti P; Piirilä P; Tuomikoski P; Sovijärvi A; Ylikorkala O; Mikkola TS
    Maturitas; 2012 Jul; 72(3):243-8. PubMed ID: 22537767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer.
    Spicer DV; Pike MC; Pike A; Rude R; Shoupe D; Richardson J
    Contraception; 1993 May; 47(5):427-44. PubMed ID: 8390340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: comparison between oral and transdermal administration of estrogen.
    Modena MG; Bursi F; Fantini G; Cagnacci A; Carbonieri A; Fortuna A; Rossi R
    Am J Med; 2002 Sep; 113(4):331-4. PubMed ID: 12361820
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement.
    Kublickiene K; Fu XD; Svedas E; Landgren BM; Genazzani AR; Simoncini T
    J Clin Endocrinol Metab; 2008 May; 93(5):1874-83. PubMed ID: 18319309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation.
    Kawano H; Motoyama T; Kugiyama K; Hirashima O; Ohgushi M; Fujii H; Ogawa H; Yasue H
    J Am Coll Cardiol; 1997 Oct; 30(4):914-9. PubMed ID: 9316518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen replacement reverses endothelial dysfunction in postmenopausal women.
    Bush DE; Jones CE; Bass KM; Walters GK; Bruza JM; Ouyang P
    Am J Med; 1998 Jun; 104(6):552-8. PubMed ID: 9674718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transdermal estradiol and lipid profile: effects on a specific group of Brazilian postmenopausal women.
    Callejon DR; Rios DR; Franceschini SA; Toloi MR
    Arq Bras Cardiol; 2009 Dec; 93(6):571-5, 617-22. PubMed ID: 20379635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of medroxyprogesterone acetate after single and multiple injection of Cyclofem in Chinese women.
    Zhou XF; Shao QX; Han XJ; Weng LJ; Sang GW
    Contraception; 1998 Jun; 57(6):405-11. PubMed ID: 9693401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute vascular effects of estrogen in postmenopausal women.
    Gilligan DM; Badar DM; Panza JA; Quyyumi AA; Cannon RO
    Circulation; 1994 Aug; 90(2):786-91. PubMed ID: 8044949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2002 Mar; 105(12):1436-9. PubMed ID: 11914251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bazedoxifene-induced vasodilation and inhibition of vasoconstriction is significantly greater than estradiol.
    Zimmerman MA; Hutson DD; Mauvais-Jarvis F; Lindsey SH
    Menopause; 2019 Feb; 26(2):172-181. PubMed ID: 30130290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women.
    Lieberman EH; Gerhard MD; Uehata A; Walsh BW; Selwyn AP; Ganz P; Yeung AC; Creager MA
    Ann Intern Med; 1994 Dec; 121(12):936-41. PubMed ID: 7978718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance.
    Kaunitz AM
    Circulation; 2003 Mar; 107(9):e67-8; author reply e67-8. PubMed ID: 12628963
    [No Abstract]   [Full Text] [Related]  

  • 39. Percutaneous estradiol/oral micronized progesterone has less-adverse effects and different gene regulations than oral conjugated equine estrogens/medroxyprogesterone acetate in the breasts of healthy women in vivo.
    Murkes D; Lalitkumar PG; Leifland K; Lundström E; Söderqvist G
    Gynecol Endocrinol; 2012 Oct; 28 Suppl 2():12-5. PubMed ID: 22834417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): a contraceptive method for women in the US and worldwide.
    Kaunitz AM; Mishell DR
    Contraception; 1999 Oct; 60(4):177-8. PubMed ID: 10640163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.